MYWOT
Child safety
Confidence
Trustworthiness
Confidence
MALICIOUS CONTENT INDICATORS
Blueoakpharma.com most likely does not offer any malicious content.
Secure connection support
HTTPS
Blueoakpharma.com provides SSL-encrypted connection.
ADULT CONTENT INDICATORS
Blueoakpharma.com most likely does not offer any adult content.
Popular pages
-
Brain Disorder Research & Drug Development | Our Science
Pioneering Innovation in Brain Disorder Research Blue Oak’s innovative dual strategy for brain disorder research and drug development identifies clinical candidates more effectively and allows us to o...
-
Startup Biotech For Brain Disorders & Mental Illness
A Startup Biotech with Validated Solutions Blue Oak is set on restoring hope for patients with brain disorders by ending decades of stagnation in the development of new neuropsychiatric drugs. We offe...
-
Brain Disorder & Central Nervous System (CNS) Treatments | Pipeline
Press Release US startup Blue Oak Pharma has joined a lengthening list of companies turning to Exscientia of the UK for its expertise in applying artificial intelligence to drug discovery. October 14,...
-
Neurobiology Research & Brain Disorder Drug Development
Lorem ipsum dolor sit amet, consectetur adipiscing elit Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Bibendum est ultrici...
-
Blue Oak and PsychoGenics Announce a Drug Discovery Partnership for Brain Disorders and Psychiatry
Companies will Work Together to Identify New Treatments for Brain Disorders BOSTON & PARAMUS, N.J.–(BUSINESS WIRE)–Blue Oak Pharmaceuticals, Inc. (Blue Oak) and PGI Drug Discovery LLC (PsychoGenics), ...
-
Thomas H. Large, Ph.D. | Blue Oak Pharmaceuticals
Thomas Large, CEO and Co-Founder, has broad leadership experience in biopharma spanning R&D, regulatory and new product planning functions as well as M&A, corporate integration and investor relations....